Infections due to ß-lactam resistant E. coli strains that produce extended-spectrum ß-lactamases (ESBL) of the CTX-M family are emerging in European countries such as the United Kingdom and Spain. In these countries, community-acquired infections caused by these strains appear to be increasingly frequent and represent a therapeutic problem, due to their multiple resistance to several antibiotic classes, including penicillins, cephalosporins, aminoglycosides and fluoroquinolones. To our knowledge, such strains have not yet been described in Belgium. We report here the emergence and rapid increase in the prevalence of CTX-M producing E. coli clinical isolates from patients attending the Erasme hospital in Brussels, Belgium.
Auteur : Rodriguez Villalobos H, Malaviolle V, Frankard J, de Mendonça R, Nonhoff C, Deplano A, Byl B, Struelens MJ
Eurosurveillance. European communicable disease quarterly, 2005, vol. 10, n°. 1-3, p. p.63